Abstract
This paper proposes an additive nanomanufacturing approach to fabricate a personalized lab-on-a-chip fluorescent peptide nanoparticles (f-PNPs) array for simultaneous multi-biomarker detection that can be used in Alzheimer’s disease (AD) diagnosis. We will discuss optimization techniques for the additive nanomanufacturing process in terms of reliability, yield and manufacturing efficiency. One contribution of this paper lies in utilization of additive nanomanufacturing techniques to fabricate a patient-specific customize-designed lab-on-a-chip device for personalized AD diagnosis, which remains a major challenge for biomedical engineering. Through the integrated bio-design and bio-manufacturing process, doctor’s check-up and computer-aided customized design are integrated into the lab-on-a-chip array for patient-specific AD diagnosis. In addition, f-PNPs with targeting moieties for personalized AD biomarkers will be self-assembled onto the customized lab-on-a-chip through the additive nanomanufacturing process, which has not been done before. Another contribution of this research is the personalized lab-on-a-chip f-PNPs array for AD diagnosis utilizing limited human blood. Blood-based AD assessment has been described as “the holy grail” of early AD detection. This research created the computer-aided design, fabrication through additive nanomanufacturing, and validation of the f-PNPs array for AD diagnosis. This is a highly interdisciplinary research contributing to nanotechnology, biomaterials, and biomedical engineering for neurodegenerative disease. The conceptual work is preliminary with intent to introduce novel techniques to the application. Large-scale manufacturing based on the proposed framework requires extensive validation and optimization.








References
Anderson JE et al (2006) Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine. Drug Resist Updates 9:198–210. https://doi.org/10.1016/j.drup.2006.08.001
Huang Y, Zhu H (2017) Protein array-based approaches for biomarker discovery in cancer. Genom Proteom Bioinform 15:73–81. https://doi.org/10.1016/j.gpb.2017.03.001
Sheridan C (2005) Protein chip companies turn to biomarkers. Nat Biotechnol 23:3–4
Romanov V et al (2014) A critical comparison of protein microarray fabrication technologies. Analyst 139:1303–1326. https://doi.org/10.1039/c3an01577g
Timm C, Niemeyer CM (2013) On-chip protein biosynthesis. Angew Chem Int Edit 52:2652–2654. https://doi.org/10.1002/anie.201208880
Engstrom D, Porter B, Pacios M, Bhaskaran H (2014) Additive nanomanufacturing—a review. J Mater Res 29:1792–1816
Gao X, Matsui H (2005) Peptide-based nanotubes and their applications in bionanotechnology. Adv Mater 17:2037–2050
Lowe CR (2000) Nanobiotechnology: the fabrication and applications of chemical and biological nanostructures. Curr Opin Struct Biol 10:428–434
Zhang D et al (2012) Bio-manufacturing technology based on diatom micro-and nanostructure. Chin Sci Bull 57:3836–3849
Huang SH, Liu P, Mokasdar A, Hou L (2013) Additive manufacturing and its societal impact: a literature review. Int J Adv Manuf Technol 67:1191–1203. https://doi.org/10.1007/s00170-012-4558-5
Ono M, Saji H (2015) Recent advances in molecular imaging probes for [small beta]-amyloid plaques. MedChemComm 6:391–402. https://doi.org/10.1039/C4MD00365A
2014-2015 Alzheimer’s Disease Progress Report: Advancing Research Toward a Cure. (National Institue on Aging/National Institues of Health, 2015)
Yue T et al (2017) Computational integration of nanoscale physical biomarkers and cognitive assessments for Alzheimer’s disease diagnosis and prognosis. Sci Adv 3:e1700669
Williams JW, Plassman BL, Burke J, Holsinger T, Benjamin S (2010) Preventing Alzheimer’s disease and cognitive decline. Agency for Healthcare Research and Quality, Rockville
Nordberg A (2004) PET imaging of amyloid in Alzheimer’s disease. Lancet Neurol 3:519–527. https://doi.org/10.1016/S1474-4422(04)00853-1
Foudeh AM, Fatanat Didar T, Veres T, Tabrizian M (2012) Microfluidic designs and techniques using lab-on-a-chip devices for pathogen detection for point-of-care diagnostics. Lab Chip 12:3249–3266. https://doi.org/10.1039/c2lc40630f
Huang YD, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:1204–1222. https://doi.org/10.1016/j.cell.2012.02.040
Doecke JD et al (2012) Blood-based protein biomarkers for diagnosis of alzheimer disease. Arch Neurol 69:1318–1325. https://doi.org/10.1001/archneurol.2012.1282
Chin CD, Linder V, Sia SK (2007) Lab-on-a-chip devices for global health: past studies and future opportunities. Lab Chip 7:41–57. https://doi.org/10.1039/b611455e
Workman J, Koch M, Veltkamp D (2005) Process analytical chemistry. Anal Chem 77:3789–3806. https://doi.org/10.1021/ac050620o
Talapatra A, Rouse R, Hardiman G (2002) Protein microarrays: challenges and promises. Pharmacogenomics 3:527–536. https://doi.org/10.1517/14622416.3.4.527
Shi LM et al (2006) The microarray quality control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24:1151–1161. https://doi.org/10.1038/nbt1239
Reches M, Gazit E (2004) Formation of closed-cage nanostructures by self-assembly of aromatic dipeptides. Nano Lett 4:581–585. https://doi.org/10.1021/nl035159z
Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296(5858):659–660
Fan Z, Sun L, Huang Y, Wang Y, Zhang M (2016) Bioinspired fluorescent dipeptide nanoparticles for targeted cancer cell imaging and real-time monitoring of drug release. Nat Nanotechnol 11:388. https://doi.org/10.1038/nnano.2015.312 https://www.nature.com/articles/nnano.2015.312#supplementary-information
Wood EJ (1985) Proteins: structures and molecular properties. In: Creighton TE (ed)
Seow WY, Hauser CAE (2014) Short to ultrashort peptide hydrogels for biomedical uses. Mater Today 17:381–388. https://doi.org/10.1016/j.mattod.2014.04.028
De Santis E, Ryadnov MG (2015) Peptide self-assembly for nanomaterials: the old new kid on the block. Chem Soc Rev 44:8288–8300. https://doi.org/10.1039/C5CS00470E
Brambilla D et al (2012) PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer’s disease. ACS Nano 6:5897–5908. https://doi.org/10.1021/nn300489k
Ghanta J, Shen CL, Kiessling LL, Murphy RM (1996) A strategy for designing inhibitors of beta-amyloid toxicity. J Biol Chem 271:29525–29528
Tjernberg LO et al (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem 271:8545–8548
Panza F et al (2014) Amyloid-based immunotherapy for Alzheimer’s disease in the time of prevention trials: the way forward. Exp Rev Clin Immunol 10:405–419. https://doi.org/10.1586/1744666x.2014.883921
Andreu D et al (1995). In: MW Pennington, BM Dunn (eds) Peptide synthesis protocols. Humana Press, pp 91–169
Rüegg UT, Rudinger J (1997) Methods in enzymology, vol 47. Academic Press, Cambridge, pp 111–116
Kingston RL, Hamel DJ, Gay LS, Dahlquist FW, Matthews BW (2004) Structural basis for the attachment of a paramyxoviral polymerase to its template. Proc Natl Acad Sci USA 101:8301–8306. https://doi.org/10.1073/pnas.0402690101
Scharre DW et al (2010) Self-administered gerocognitive examination (SAGE): a brief cognitive assessment instrument for mild cognitive impairment (MCI) and early dementia. Alzheimer Dis Assoc Disord 24:64–71. https://doi.org/10.1097/WAD.0b013e3181b03277
Sun L et al (2015) Tunable synthesis of self-assembled cyclic peptide nanotubes and nanoparticles. Soft Matter 11:3822–3832. https://doi.org/10.1039/c5sm00533g
Yue T et al (2014) On-chip self-assembly of cell embedded microstructures to vascular-like microtubes. Lab Chip 14:1151–1161. https://doi.org/10.1039/c3lc51134k
Yue T et al (2016) Quantifying drug-induced nanomechanics and mechanical effects to single cardiomyocytes for optimal drug administration to minimize cardiotoxicity. Langmuir 32:1909–1919. https://doi.org/10.1021/acs.langmuir.5b04314
Martinez CR, Iverson BL (2012) Rethinking the term “pi-stacking”. Chem Sci 3:2191–2201. https://doi.org/10.1039/C2SC20045G
Zhang M, Wu J, Wang L, Xiao K, Wen W (2010) A simple method for fabricating multi-layer PDMS structures for 3D microfluidic chips. Lab Chip 10:1199–1203. https://doi.org/10.1039/b923101c
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, L., Fan, Z., Yue, T. et al. Additive nanomanufacturing of lab-on-a-chip fluorescent peptide nanoparticle arrays for Alzheimer’s disease diagnosis. Bio-des. Manuf. 1, 182–194 (2018). https://doi.org/10.1007/s42242-018-0019-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42242-018-0019-9